Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating transplantation of human umbilical cord mesenchymal stem cells in patients with decompensated liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Beike Bio-Technology Co., Ltd. | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED